State and local law enforcement officials came to Capitol Hill last week to protest a Trump Administration proposal to move oversight of a drug prevention program from the Office of National Drug Control Policy to the Justice Department.
Representative Tom Marino of Pennsylvania announced this week he is withdrawing his name from consideration as head of the White House Office of National Drug Control Policy. His decision comes in the wake of a Washington Post and 60 Minutes joint report that concluded legislation Marino sponsored hampered efforts by the Drug Enforcement Administration to fight the opioid epidemic.
The White House is proposing a cut of 94 percent to the budget of the Office of National Drug Control Policy, according to an e-mail to agency employees by Acting Director Richard Baum. He asked employees not to share the information, but the e-mail was quickly leaked, NPR reports.
Fentanyl, the opioid that is up to 50 times as potent as heroin, is presenting law enforcement with complex challenges, according to Richard Baum, Acting Director of the White House Office of National Drug Control Policy.
Repealing the Affordable Care Act would roll back any progress made against combating the nation’s opioid crisis, according to Michael Botticelli, Director of the White House Office of National Drug Control Policy under President Obama.
A national group of anesthesiologists is launching a card to identify and treat people suspected of an opioid overdose. The American Society of Anesthesiologists’ Opioid Overdose Resuscitation card lists symptoms and instructions for helping a person suspected of an overdose.
Gil Kerlikowske will leave his post as Director of the Office of National Drug Control Policy, according to the Seattle Post-Intelligencer. He was nominated by President Obama on Friday to become the new U.S. Commissioner of Customs.